GL1X · GenesisL1 explorer

Research workbench

Bacteroides thetaiotaomicron GH84 O-glcnacase in complex with N-butyl-thiazoline inhibitor

Analyse Bacteroides thetaiotaomicron GH84 O-glcnacase in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2J4G
Type
protein
Length
1,166 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hyaluronoglucosaminidase
EC
3.2.1.52
UniProt
Q89ZI2
Ligands
NB1
Pockets
16 · best druggability 0.60

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHyaluronoglucosaminidase (EC 3.2.1.52)protein58646% helix, 14% strandQ89ZI2
BHyaluronoglucosaminidase (EC 3.2.1.52)protein58045% helix, 15% strandQ89ZI2

Ligands and binding sites

  • NB1 · (3ar,5r,6s,7r,7ar)-5-(hydroxymethyl)-2-propyl-5,6,7,7A-tetrahydro-3AH-pyrano[3,2-d][1,3]thiazole-6,7-diol · ligand · 2 copies · chains A, B
  • ACT · Acetate ion · additive · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11060.600.8624NB1, ACT, GOL
21110.580.8525NB1, GOL
31470.430.7524ACT
41170.420.7719empty
51160.380.7420empty

Compared structures

  • 2J4G · Bacteroides thetaiotaomicron GH84 O-GlcNAcase in complex with n-butyl- thiazoline… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q89ZI2 · AlphaFold monomer V2.0 prediction for O-glcnacase BT_4395 (Q89ZI2) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.